Medicine-Hinews / 하이뉴스

ROKIT Healthcare Inks Supply Deal with Alliant Purchasing via Tides Medical Partnership

SEOUL, South Korea — August 18, 2025 — ROKIT Healthcare, a South Korean biotechnology firm specializing in regenerative medicine, announced Monday that it has entered into a supply agreement with Alliant Purchasing, a prominent U.S. group purchasing organization (GPO) representing over 35,000 healthcare facilities nationwide.Facilitated by ROKIT’s U.S. partner, Tides Medical, the agreement enables Alliant’s member hospitals and clinics to access ROKIT’s advanced regenerative medicine products. Alliant collaborates with healthcare systems to secure bulk purchasing contracts, balancing cost
Medicine Kim Kuk Ju, HEALTH IN NEWS TEAM 2025.08.18 14:28
Onconic Therapeutics’ GERD Drug Zastaprazan Completes Phase 3 Trials in China, Targets $36 Billion Global Market

SEOUL, South Korea — Onconic Therapeutics (KOSDAQ: 476060), a South Korean biopharmaceutical company, announced that its gastroesophageal reflux disease (GERD) drug Zastaprazan, marketed as Zacubo, has successfully completed Phase 3 clinical trials in China, paving the way for a New Drug Application (NDA) submission to China’s National Medical Products Administration (NMPA). The milestone, achieved in collaboration with Chinese partner Livzon Pharmaceutical Group, signals Onconic’s accelerating push into the global GERD market, projected to reach $36 billion by 2025.Livzon, China’s leading
Medicine Kim Kuk Ju, HEALTH IN NEWS TEAM 2025.08.18 13:46
Celltrion Publishes 3-Year Trial Results for Avastin Biosimilar Vegzelma in Lung Cancer

Celltrion has published three-year clinical trial results for its Avastin biosimilar, Vegzelma (CT-P16), in the international oncology journal Cancer Treatment and Research Communications.The study presents long-term follow-up data from a global phase 3 trial evaluating the efficacy, safety, immunogenicity, and pharmacokinetics of Vegzelma in 689 patients with metastatic non-small cell lung cancer.Patients were randomized in a 1:1 ratio to receive either Vegzelma or the reference product Avastin, beginning with induction therapy every three weeks followed by maintenance monotherapy, with outco
Medicine Kim Kuk Ju, HEALTH IN NEWS TEAM 2025.07.31 16:54
Cellid Secures European Patent for Adenovirus Vector Technology in COVID-19 Vaccine Development

SEOUL, South Korea — Cellid Co. (KOSDAQ: 299660), a South Korean biotechnology company, announced on July 29, 2025, that it has received a European patent for its proprietary adenovirus vector platform, used in its COVID-19 vaccine candidate AdCLD-CoV19-1 OMI.The patent covers an optimized vector structure designed for large-scale production of replication-incompetent adenoviruses. This achievement follows similar patent approvals in South Korea, the United States, China, Japan, and Russia, with applications still under review in Vietnam, Indonesia, Thailand, and Brazil. During the production
Medicine Kim Kuk Ju, HEALTH IN NEWS TEAM 2025.07.31 16:39
FirstBioTherapeutics Joins NVIDIA Inception Program to Advance AI-Driven Drug Discovery

SEOUL, South Korea — FirstBioTherapeutics, a biotechnology startup based in South Korea, announced on July 30 that it has been selected to join NVIDIA’s Inception program—a global initiative that supports startups leveraging artificial intelligence, data science, and high-performance computing.Through NVIDIA Inception program, selected companies gain access to GPU technologies, software development tools, technical training, and venture capital connections—aimed at accelerating innovation in frontier industries.FirstBioTherapeutics is applying AI technologies to improve the speed and accur
Medicine Kim Kuk Ju, HEALTH IN NEWS TEAM 2025.07.31 16:30
Caregen’s Korglutide Gains Approval as Health Supplement in India for Weight Loss

SEOUL, South Korea — Caregen, a South Korean biotech company specializing in peptide therapeutics, announced on July 30 that its weight-management peptide, Korglutide, has been officially approved as a health supplement by Indian health authorities.This regulatory milestone paves the way for Caregen to distribute and commercialize Korglutide in India, one of the world’s fastest-growing health and wellness markets. Korglutide, an oral glucagon-like peptide-1 (GLP-1) receptor agonist, offers a competitive edge over injectable GLP-1 therapies by providing user convenience and helping to preserv
Medicine Kim Kuk Ju, HEALTH IN NEWS TEAM 2025.07.31 16:25
Seoul National University Hospital Team Identifies Blood-Based Biomarker for Early Moyamoya Disease Diagnosis

SEOUL, South Korea — A research team at Seoul National University Hospital has achieved a significant breakthrough in diagnosing moyamoya disease—a rare pediatric cerebrovascular disorder—by identifying a novel blood-based biomarker. The microRNA marker, miR-512-3p, shows promise as a non-invasive diagnostic tool, potentially reducing reliance on high-risk procedures such as cerebral angiography.Moyamoya disease is a progressive condition marked by narrowing of the brain’s major arteries and the formation of abnormal collateral vessels. Predominantly affecting children, it can lead to seri
Medicine Lim Hye Jung, HEALTH IN NEWS TEAM 2025.07.31 16:22
South Korean Team at Asan Medical Center Develops Nanoparticle for Targeted Asthma Therapy

SEOUL, South Korea — A research team led by Professor Jun-o Jin at the University of Ulsan College of Medicine and Asan Medical Center has developed a novel nanoparticle that selectively targets immune cells—offering a promising new approach to asthma treatment with fewer side effects. The findings were published in ACS Nano, a leading journal in nanoscience (Impact Factor: 16.0).Named DM-HNP, the hybrid nanoparticle carries the corticosteroid dexamethasone and is engineered to bind specifically to dendritic cells and macrophages. Its surface is modified with MPLA, a molecule that binds to t
Medicine Lim Hye Jung, HEALTH IN NEWS TEAM 2025.07.29 11:59
South Korean Researchers Patent Advanced Type 2 Diabetes Prediction System

SEOUL, South Korea — Researchers at Korea University Anam Hospital have developed an innovative diabetes prediction system that integrates clinical and genetic data to assess individual risk. The system has received a domestic patent and represents a major step forward in personalized medicine for type 2 diabetes.The project was led by Dr. Nan-Hee Kim of the Department of Endocrinology and Metabolism, with Drs. So-Young Park, Min-Hee Kim, and Jae-Young Kim. The system forecasts diabetes risk using clinical indicators and genetic markers tailored to specific ethnic populations.Type 2 diabetes,
Medicine Lim Hye Jung, HEALTH IN NEWS TEAM 2025.07.26 14:54
OrganoidScience Launches Texas Subsidiary to Bolster U.S. Market Presence

AUSTIN, Texas — OrganoidScience, a South Korean biotechnology firm, announced on July 25, 2025, the launch of its U.S. subsidiary, Organoids by Southwest, headquartered in Texas. The July 22 launch marks a strategic expansion into the American market. Departing from the industry’s usual focus on Boston or Silicon Valley, the company has designated Austin and Houston as operational hubs, while its Boston office will continues cultivating East Coast partnerships.The Texas subsidiary will focus on integrating healthcare technologies and advancing the commercialization of organoid-based therapeu
Medicine Kim Kuk Ju, HEALTH IN NEWS TEAM 2025.07.25 13:47
Daewoong Pharmaceutical Bolsters Biosimilar Business for Global Expansion

SEOUL, South Korea — Daewoong Pharmaceutical, a leading South Korean drugmaker, is positioning its biosimilar division as a key growth engine, establishing partnerships with domestic and international companies to cover the full spectrum of development and commercialization. The company has appointed Dr. Seung-suh Hong to lead its newly launched Biosimilar Business Division, signaling a bold push into global markets.Dr. Hong, a biosimilar specialist with two decades of experience at Celltrion, where he led major R&D and commercialization initiatives, will spearhead Daewoong's global expansion
Medicine Kim Kuk Ju, HEALTH IN NEWS TEAM 2025.07.24 14:47
South Korean Breakthrough in Rapid Detection of E. coli and Listeria in Food

A South Korean research team has developed a novel gene-based diagnostic technology that rapidly detects foodborne pathogens such as Escherichia coli and Listeria monocytogenes, drawing global attention from the scientific community.Led by Professor Ki-Soo Park of Konkuk University’s Department of Biological Engineering, the research team introduced the “M-FLASH” (Modification-Free Lateral Flow Assay for Specific Hybridization) system, which detects foodborne pathogens without requiring complex equipment or sample preprocessing. The technology was featured as the cover story of the July 202
Medicine Lim Hye Jung, HEALTH IN NEWS TEAM 2025.07.22 19:28
Korea Kolmar Bolsters U.S. Production with New Factory, Targets 300 Million Annual Output

SCOTT TOWNSHIP, Pa. — Korea Kolmar, a leading cosmetics manufacturer, officially opened its second U.S. factory on July 16, significantly boosting its production capacity in the American market. The opening ceremony, held in Scott Township, Pennsylvania, was attended by over 100 guests, including Korea Kolmar Vice Chairman Sang-hyun Yoon, Pennsylvania State Representative Bridget Kosierowski, state officials, and representatives from client companies.The new facility, spanning 17,805 square meters, is designed to produce approximately 120 million cosmetic products annually. Together with its
Medicine Haeun Oh, HEALTH IN NEWS TEAM 2025.07.21 12:50
Low Income Tied to Increased Risk of Severe Hypoglycemia in Type 2 Diabetes, Study Reveals

A research team led by Professor Jae-seung Yun at The Catholic University of Korea’s St. Vincent’s Hospital has identified income level as a pivotal factor affecting health outcomes for patients with type 2 diabetes. The study found that patients in the lower income groups faced a heightened risk of hypoglycemia—a condition in which blood sugar drops to dangerously low levels, potentially causing confusion, seizures, or loss of consciousness—compared to those with higher incomes.The study analyzed health data and income trends from approximately 1.85 million patients with type 2 diabetes i
Medicine Lim Hye Jung, HEALTH IN NEWS TEAM 2025.07.16 10:30
Dongsung Pharmaceutical Sees Over 300% Sales Surge on Amazon Prime Day 2025

SEOUL, South Korea — Dongsung Pharmaceutical Co., Ltd. reported that its sales on the first day of Amazon Prime Day 2025 (beginning July 8) surged over 300% compared to average daily figures. Overall sales during the four-day event doubled, further solidifying the company’s presence in the North American market.The 2025 four-day Prime Day event set a new record, with U.S. online sales hitting $24.1 billion—a 30% increase from 2024. Dongsung Pharmaceutical posted strong performance with its premium hair dye brand eZn and its clean beauty line Herb.The Herb Speedy Color Cream, made with vegan
Medicine Kim Kuk Ju, HEALTH IN NEWS TEAM 2025.07.16 09:38
Understanding Osgood-Schlatter Disease: A Common Cause of Knee Pain in Growing Children

[Physician's Column] By Jeong-Hyun Yoo, Guseong Seoul Orthopedic ClinicParents often attribute knee pain in children and adolescents to "growing pains." These discomforts arise when the periosteum, the membrane encasing bones, stretches and stimulates surrounding nerves as bones grow faster than adjacent muscles or tendons. Typically, such pains resolve without intervention. Yet, if pain, swelling, or warmth persists despite limited activity or typical growth, it may indicate a different condition. A medical evaluation is essential to identify the cause.One frequent knee issue in adolescents i
Medicine Kim Kuk Ju, HEALTH IN NEWS TEAM 2025.06.25 18:16
GentleMax Pro Laser Hair Removal: Preparing Skin for Summer

[Physician's Column] By Min-gyun Na, All Line ClinicSummer's arrival brings lighter clothing and greater skin exposure, underscoring the importance of meticulous grooming. Laser hair removal has become a favored approach for facial and body treatments, delivering both aesthetic refinement and hygienic benefits.The GentleMax Pro, a leading hair removal system, has gained prominence in dermatology for its efficacy across diverse skin types and hair textures. It employs a dual-wavelength platform—Alexandrite (755 nm) and Nd:YAG (1064 nm)—enabling customized treatments. Unlike traditional method
Medicine Lim Hye Jung, HEALTH IN NEWS TEAM 2025.06.25 18:10
Understanding Cataract Care and Surgery: A Guide for Aging Eyes

[Physician's Column] By Dr. Jin Woo Ro, Kangnam The Light Eye Center, Gwangju, KoreaAs populations age worldwide, cataract cases are rising sharply. Many patients mistake cataracts for presbyopia or delay treatment until symptoms become severe. Ophthalmologists stress that early diagnosis and systematic management are essential for optimal outcomes.Cataracts occur when the eye’s clear lens becomes opaque, leading to blurred vision. Aging is the primary cause, but diabetes, trauma, or prolonged ultraviolet exposure can also trigger the condition. Early symptoms often include glare from bright
Medicine Lim Hye Jung, HEALTH IN NEWS TEAM 2025.06.25 16:22
Spinal Stenosis: Symptoms, Diagnosis, and Treatment Options for Aging Adults

[Physician's Column] By Dr. Kyungwoo Park, Director of Kwanghye Spine Hospital.Lower back pain is a frequent complaint among middle-aged and older adults, often brushed off as an unavoidable part of aging. Many reach for over-the-counter pain relievers or heating patches, chalking up their discomfort to a weekend of overexertion or poor posture. Yet this dismissive approach can obscure serious conditions. Spinal stenosis, nearly as common as herniated discs in older populations, can severely diminish mobility and quality of life if not addressed early.The spine, the body’s central pillar, beg
Medicine Kim Kuk Ju, HEALTH IN NEWS TEAM 2025.06.19 23:00
Stem Cell IV Therapy: A Promising Anti-Aging Solution at CELLTING Clinic

[Physician's Column] By Dr. Sang A Yoon, Director of CELLTING Clinic, CheongdamAs aging populations worldwide fuel heightened interest in health and appearance, stem cell intravenous (IV) therapy has emerged as a sought-after anti-aging intervention. Patients are drawn to its potential to address declining skin elasticity, wrinkles, and fatigue, while also enhancing physical recovery and immune function.Stem cells, with their unique capacity to regenerate and repair damaged cells, are administered intravenously to deliver systemic anti-aging benefits across the body.This therapy channels stem
Medicine Lim Hye Jung, HEALTH IN NEWS TEAM 2025.06.19 21:10

모바일화면 이동